# Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

> **NCT02960399** · NA · TERMINATED · sponsor: **University of South Florida** · enrollment: 2 (actual)

## Conditions studied

- Common Variable Immune Deficiency
- Specific Antibody Deficiency
- X-linked Agammaglobulinemia

## Interventions

- **BIOLOGICAL:** Zostavax®

## Key facts

- **NCT ID:** NCT02960399
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** PI has terminated the study at this time.
- **Last updated:** 2018-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960399, "Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT02960399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*